{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T05:32:32Z","timestamp":1775194352117,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T00:00:00Z","timestamp":1712793600000},"content-version":"vor","delay-in-days":346,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Medicine"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.7861\/clinmed2023-0076","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T17:25:33Z","timestamp":1685121933000},"page":"234-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["How to approach acute thrombosis and thrombocytopenia"],"prefix":"10.1016","volume":"23","author":[{"given":"Jeremy","family":"Schofield","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Hock","family":"Toh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.7861\/clinmed2023-0076_bib1","series-title":"Updated Brighton Collaboration case definition for Thrombosis with Thrombocytopenia Syndrome (TTS) 2021","author":"Chen","year":"2021"},{"key":"10.7861\/clinmed2023-0076_bib2","doi-asserted-by":"crossref","first-page":"100274","DOI":"10.1016\/j.lanepe.2021.100274","article-title":"Most cases of thrombosis and thrombocytopenia syndrome (TTS) post ChAdOx-1 nCov-19 are vaccine-induced immune thrombotic thrombocytopenia (VITT)","volume":"12","author":"Makris","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"10.7861\/clinmed2023-0076_bib3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/jth.15572","article-title":"Vaccine-induced immune thrombotic thrombocytopenia (VITT): update on diagnosis and management considering different resources","volume":"20","author":"Greinacher","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.7861\/clinmed2023-0076_bib4","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1182\/blood-2016-10-709857","article-title":"Thrombotic thrombocytopenic purpura","volume":"129","author":"Joly","year":"2017","journal-title":"Blood"},{"key":"10.7861\/clinmed2023-0076_bib5","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/bloodadvances.2017007989","article-title":"ITP and thrombosis: an intriguing association","volume":"1","author":"Rodeghiero","year":"2017","journal-title":"Blood Adv"},{"key":"10.7861\/clinmed2023-0076_bib6","doi-asserted-by":"crossref","first-page":"16037","DOI":"10.1038\/nrdp.2016.37","article-title":"Disseminated intravascular coagulation","volume":"2","author":"Gando","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.7861\/clinmed2023-0076_bib7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.semcancer.2021.07.011","article-title":"Neutrophil extracellular traps in cancer","volume":"79","author":"Cristinziano","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"10.7861\/clinmed2023-0076_bib8","first-page":"282","article-title":"Managing thrombocytopenia associated with cancer chemotherapy","volume":"29","author":"Kuter","year":"2015","journal-title":"Oncology (Williston Park)"},{"key":"10.7861\/clinmed2023-0076_bib9","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1002\/cncr.24480","article-title":"Etiology and outcome of extreme leukocytosis in 758 nonhematologic cancer patients","volume":"115","author":"Granger","year":"2009","journal-title":"Cancer"},{"key":"10.7861\/clinmed2023-0076_bib10","doi-asserted-by":"crossref","first-page":"13076","DOI":"10.1073\/pnas.1200419109","article-title":"Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis","volume":"109","author":"Demers","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.7861\/clinmed2023-0076_bib11","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/jth.13951","article-title":"Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients","volume":"16","author":"Mauracher","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.7861\/clinmed2023-0076_bib12","series-title":"Venous thromboembolic diseases: diagnosis, management and thrombophilia testing","year":"2020"},{"key":"10.7861\/clinmed2023-0076_bib13","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/jth.14015","article-title":"Management of cancer-associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH","volume":"16","author":"Samuelson Bannow","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.7861\/clinmed2023-0076_bib14","doi-asserted-by":"crossref","first-page":"E468","DOI":"10.1002\/ajh.24526","article-title":"Venous thromboembolism in patients with hematologic malignancy and thrombocytopenia","volume":"91","author":"Khanal","year":"2016","journal-title":"Am J Hematol"},{"key":"10.7861\/clinmed2023-0076_bib15","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/rth2.12111","article-title":"Management of anticoagulation for cancer-associated thrombosis in patients with thrombocytopenia: a systematic review","volume":"2","author":"Samuelson Bannow","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"key":"10.7861\/clinmed2023-0076_bib16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.thromres.2017.03.012","article-title":"Inferior vena cava filters in patients with cancer and venous thromboembolism (VTE) does not improve clinical outcomes: a population-based study","volume":"153","author":"Brunson","year":"2017","journal-title":"Thromb Res"},{"key":"10.7861\/clinmed2023-0076_bib17","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0002-9343(96)00258-6","article-title":"A 14-year study of heparin-induced thrombocytopenia","volume":"101","author":"Warkentin","year":"1996","journal-title":"Am J Med"},{"key":"10.7861\/clinmed2023-0076_bib18","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","volume":"2","author":"Cuker","year":"2018","journal-title":"Blood Adv"},{"key":"10.7861\/clinmed2023-0076_bib19","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.06-2109","article-title":"The incidence of recognized heparin-induced thrombocytopenia in a large, tertiary care teaching hospital","volume":"131","author":"Smythe","year":"2007","journal-title":"Chest"},{"key":"10.7861\/clinmed2023-0076_bib20","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1182\/blood-2005-11-012450","article-title":"Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia","volume":"108","author":"Warkentin","year":"2006","journal-title":"Blood"},{"key":"10.7861\/clinmed2023-0076_bib21","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood.V96.5.1703","article-title":"Impact of the patient population on the risk for heparin-induced thrombocytopenia","volume":"96","author":"Warkentin","year":"2000","journal-title":"Blood"},{"key":"10.7861\/clinmed2023-0076_bib22","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1182\/blood-2016-11-709873","article-title":"Heparin-induced thrombocytopenia","volume":"129","author":"Arepally","year":"2017","journal-title":"Blood"},{"key":"10.7861\/clinmed2023-0076_bib23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1538-7836.2009.03385.x","article-title":"Heparin-induced thrombocytopenia","volume":"7","author":"Greinacher","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.7861\/clinmed2023-0076_bib24","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1182\/blood.V96.1.182","article-title":"Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4\u2013heparin antibodies to platelets and the resultant platelet activation","volume":"96","author":"Newman","year":"2000","journal-title":"Blood"},{"key":"10.7861\/clinmed2023-0076_bib25","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s41467-019-09160-7","article-title":"Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia","volume":"10","author":"Perdomo","year":"2019","journal-title":"Nat Commun"},{"key":"10.7861\/clinmed2023-0076_bib26","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1538-7836.2006.01787.x","article-title":"Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings","volume":"4","author":"Lo","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.7861\/clinmed2023-0076_bib27","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1182\/blood-2012-07-443051","article-title":"Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis","volume":"120","author":"Cuker","year":"2012","journal-title":"Blood"},{"key":"10.7861\/clinmed2023-0076_bib28","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/ckj\/sft139","article-title":"Heparin-induced thrombocytopenia (HIT)-an overview: what does the nephrologist need to know and do?","volume":"6","author":"Dutt","year":"2013","journal-title":"Clin Kidney J"},{"key":"10.7861\/clinmed2023-0076_bib29","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1182\/blood-2017-04-778993","article-title":"Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review","volume":"130","author":"Warkentin","year":"2017","journal-title":"Blood"},{"key":"10.7861\/clinmed2023-0076_bib30","doi-asserted-by":"crossref","first-page":"804","DOI":"10.7326\/0003-4819-127-9-199711010-00005","article-title":"The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia","volume":"127","author":"Warkentin","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.7861\/clinmed2023-0076_bib31","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1182\/blood-2002-05-1448","article-title":"Central venous catheters and upper-extremity deep-vein thrombosis complicating immune heparin-induced thrombocytopenia","volume":"101","author":"Hong","year":"2003","journal-title":"Blood"},{"key":"10.7861\/clinmed2023-0076_bib32","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1182\/blood-2014-10-605493","article-title":"Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality","volume":"125","author":"Goel","year":"2015","journal-title":"Blood"},{"key":"10.7861\/clinmed2023-0076_bib33","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.7861\/clinmed2023-0076_bib34","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.autrev.2016.09.010","article-title":"Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of 500 patients from the International CAPS Registry","volume":"15","author":"Rodr\u00edguez-Pint\u00f3","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.7861\/clinmed2023-0076_bib35","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients","volume":"74","author":"Cervera","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.7861\/clinmed2023-0076_bib36","doi-asserted-by":"crossref","first-page":"100610","DOI":"10.1016\/j.blre.2019.100610","article-title":"The role of beta-2-glycoprotein I in health and disease associating structure with function: more than just APS","volume":"39","author":"McDonnell","year":"2020","journal-title":"Blood Rev"},{"key":"10.7861\/clinmed2023-0076_bib37","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1111\/j.1538-7836.2011.04532.x","article-title":"Induction of anti-\u03b22-glycoprotein I autoantibodies in mice by protein H of Streptococcus pyogenes","volume":"9","author":"van Os","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"21","key":"10.7861\/clinmed2023-0076_bib38","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1056\/NEJMra1705454","article-title":"Diagnosis and management of the antiphospholipid syndrome","volume":"378","author":"Garcia","year":"2018","journal-title":"N Engl J Med"},{"key":"10.7861\/clinmed2023-0076_bib39","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1002\/art.39247","article-title":"Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome","volume":"67","author":"Yalavarthi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.7861\/clinmed2023-0076_bib40","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.4049\/jimmunol.177.7.4794","article-title":"A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways","volume":"177","author":"Ritis","year":"2006","journal-title":"J Immunol"},{"key":"10.7861\/clinmed2023-0076_bib41","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1182\/blood.2019003863","article-title":"Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS","volume":"135","author":"Chaturvedi","year":"2020","journal-title":"Blood"},{"key":"10.7861\/clinmed2023-0076_bib42","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00124743-200206000-00008","article-title":"Catastrophic antiphospholipid syndrome: proposed guidelines for diagnosis and treatment","volume":"8","author":"Asherson","year":"2002","journal-title":"J Clin Rheumatol"},{"key":"10.7861\/clinmed2023-0076_bib43","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1111\/jth.14192","article-title":"McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome","volume":"16","author":"Legault","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.7861\/clinmed2023-0076_bib44","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.7861\/clinmed2023-0076_bib45","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.autrev.2014.03.002","article-title":"14th international congress on antiphospholipid antibodies task force report on catastrophic antiphospholipid syndrome","volume":"13","author":"Cervera","year":"2014","journal-title":"Autoimmunity Rev"},{"key":"10.7861\/clinmed2023-0076_bib46","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical features of vaccine-induced immune thrombocytopenia and thrombosis","volume":"385","author":"Pavord","year":"2021","journal-title":"N Engl J Med"},{"key":"10.7861\/clinmed2023-0076_bib47","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/S2352-3026(21)00306-9","article-title":"Vaccine-induced immune thrombotic thrombocytopenia","volume":"9","author":"Klok","year":"2022","journal-title":"Lancet Haematol"},{"key":"10.7861\/clinmed2023-0076_bib48","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-021-03744-4","article-title":"Antibody epitopes in vaccine-induced immune thrombotic thrombocytopenia","volume":"596","author":"Huynh","year":"2021","journal-title":"Nature"},{"key":"10.7861\/clinmed2023-0076_bib49","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1182\/blood.2021013839","article-title":"The interaction between anti-PF4 antibodies and anticoagulants in vaccine-induced thrombotic thrombocytopenia","volume":"139","author":"Singh","year":"2022","journal-title":"Blood"},{"key":"10.7861\/clinmed2023-0076_bib50","doi-asserted-by":"crossref","first-page":"140","DOI":"10.7861\/clinmed.2022-0006","article-title":"The aetiopathogenesis of vaccine-induced immune thrombotic thrombocytopenia","volume":"22","author":"Toh","year":"2022","journal-title":"Clin Med (Lond)"},{"key":"10.7861\/clinmed2023-0076_bib51","series-title":"Guidance produced from the expert haematology panel (EHP) focussed on Covid-19 vaccine induced thrombosis and thrombocytopenia (VITT). Updated Guidance on Management","author":"Pavord","year":"2021"},{"key":"10.7861\/clinmed2023-0076_bib52","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/ejh.13665","article-title":"COVID-19 Vaccine-associated immune thrombosis and thrombocytopenia (VITT): diagnostic and therapeutic recommendations for a new syndrome","volume":"107","author":"Franchini","year":"2021","journal-title":"Eur J Haematol"},{"key":"10.7861\/clinmed2023-0076_bib53","unstructured":"53 Accord Healthcare Limited,. Argatroban 1 mg\/ml solution for infusion 2022. www.medicines.org.uk\/emc\/product\/10036\/dhpcs#gref [Accessed 18 April 2023]."},{"key":"10.7861\/clinmed2023-0076_bib54","series-title":"COVID-19 rapid guideline: vaccine-induced immune thrombocytopenia and thrombosis (VITT)","year":"2022"},{"key":"10.7861\/clinmed2023-0076_bib55","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1053\/j.seminhematol.2007.02.004","article-title":"Epidemiology and risk factors for venous thrombosis","volume":"44","author":"Cushman","year":"2007","journal-title":"Semin Hematol"},{"key":"10.7861\/clinmed2023-0076_bib56","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1111\/j.1538-7836.2010.03986.x","article-title":"Venous thrombosis in the elderly: incidence, risk factors and risk groups","volume":"8","author":"Engbers","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.7861\/clinmed2023-0076_bib57","doi-asserted-by":"crossref","first-page":"886","DOI":"10.7326\/0003-4819-129-11_Part_1-199812010-00009","article-title":"Drug-induced thrombocytopenia: a systematic review of published case reports","volume":"129","author":"George","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.7861\/clinmed2023-0076_bib58","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0140-6736(98)10265-9","article-title":"Thrombosis in pregnancy: maternal and fetal issues","volume":"353","author":"Greer","year":"1999","journal-title":"Lancet"},{"key":"10.7861\/clinmed2023-0076_bib59","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1802897","article-title":"Platelet counts during pregnancy","volume":"379","author":"Reese","year":"2018","journal-title":"N Engl J Med"},{"key":"10.7861\/clinmed2023-0076_bib60","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1182\/blood.2021013231","article-title":"Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia","volume":"138","author":"Greinacher","year":"2021","journal-title":"Blood"},{"key":"10.7861\/clinmed2023-0076_bib61","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1002\/art.41460","article-title":"Anti-neutrophil extracellular trap antibodies and impaired neutrophil extracellular trap degradation in antiphospholipid syndrome","volume":"72","author":"Zuo","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.7861\/clinmed2023-0076_bib62","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1182\/blood-2012-06-434985","article-title":"Platelet factor 4 binding to lipid A of Gram-negative bacteria exposes PF4\/heparin-like epitopes","volume":"120","author":"Krauel","year":"2012","journal-title":"Blood"},{"key":"10.7861\/clinmed2023-0076_bib63","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.seminhematol.2022.02.005","article-title":"Platelet-activating anti-PF4 disorders: an overview","volume":"59","author":"Warkentin","year":"2022","journal-title":"Semin Hematol"},{"key":"10.7861\/clinmed2023-0076_bib64","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/jth.15604","article-title":"Thrombosis and thrombocytopenia after HPV vaccination","volume":"20","author":"Johansen","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.7861\/clinmed2023-0076_bib65","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.thromres.2021.05.018","article-title":"Spontaneous HIT syndrome: knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia","volume":"204","author":"Warkentin","year":"2021","journal-title":"Thromb Res"}],"container-title":["Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211824046062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211824046062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.7861\/clinmed2023-0076","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T08:50:52Z","timestamp":1744447852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470211824046062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1470211824046062"],"URL":"https:\/\/doi.org\/10.7861\/clinmed2023-0076","relation":{},"ISSN":["1470-2118"],"issn-type":[{"value":"1470-2118","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How to approach acute thrombosis and thrombocytopenia","name":"articletitle","label":"Article Title"},{"value":"Clinical Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.7861\/clinmed2023-0076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 Royal College of Physicians 2023. All rights reserved.","name":"copyright","label":"Copyright"}]}}